Literature DB >> 12045253

Acinar-to-ductal metaplasia in pancreatic cancer development.

Roland M Schmid1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12045253      PMCID： PMC151004          DOI： 10.1172/JCI15889

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease.

Authors:  M Wagner; F R Greten; C K Weber; S Koschnick; T Mattfeldt; W Deppert; H Kern; G Adler; R M Schmid
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

2.  p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.

Authors:  C A Moskaluk; R H Hruban; S E Kern
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

3.  Expansion of Pdx1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha.

Authors:  S Y Song; M Gannon; M K Washington; C R Scoggins; I M Meszoely; J R Goldenring; C R Marino; E P Sandgren; R J Coffey; C V Wright; S D Leach
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

4.  Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro.

Authors:  I Rooman; Y Heremans; H Heimberg; L Bouwens
Journal:  Diabetologia       Date:  2000-07       Impact factor: 10.122

5.  Focal acinar cell dysplasia in human pancreas.

Authors:  D S Longnecker; H Shinozuka; A Dekker
Journal:  Cancer       Date:  1980-02       Impact factor: 6.860

6.  Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas.

Authors:  Howard C Crawford; Charles R Scoggins; M Kay Washington; Lynn M Matrisian; Steven D Leach
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

7.  Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions.

Authors:  R H Hruban; N V Adsay; J Albores-Saavedra; C Compton; E S Garrett; S N Goodman; S E Kern; D S Klimstra; G Klöppel; D S Longnecker; J Lüttges; G J Offerhaus
Journal:  Am J Surg Pathol       Date:  2001-05       Impact factor: 6.394

8.  Insulin-promoter-factor 1 is required for pancreas development in mice.

Authors:  J Jonsson; L Carlsson; T Edlund; H Edlund
Journal:  Nature       Date:  1994-10-13       Impact factor: 49.962

9.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

Authors:  M F Offield; T L Jetton; P A Labosky; M Ray; R W Stein; M A Magnuson; B L Hogan; C V Wright
Journal:  Development       Date:  1996-03       Impact factor: 6.868
  9 in total
  23 in total

Review 1.  Pancreatic stem cells: differentiation options.

Authors:  M Sambasiva Rao; Janardan K Reddy
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

2.  Expression of the Notch signaling pathway and effect on exocrine cell proliferation in adult rat pancreas.

Authors:  Ilse Rooman; Nele De Medts; Luc Baeyens; Jessy Lardon; Saskia De Breuck; Harry Heimberg; Luc Bouwens
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

3.  A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm).

Authors:  Anna Sanchez Calle; Neha Nair; Aung KoKo Oo; Marta Prieto-Vila; Megumi Koga; Apriliana Cahya Khayrani; Maram Hussein; Laura Hurley; Arun Vaidyanath; Akimasa Seno; Yoshiaki Iwasaki; Malu Calle; Tomonari Kasai; Masaharu Seno
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

4.  Onecut transcription factors in development and disease.

Authors:  Peter A Kropp; Maureen Gannon
Journal:  Trends Dev Biol       Date:  2016

5.  Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.

Authors:  Shalini Makawita; Chris Smith; Ihor Batruch; Yingye Zheng; Felix Rückert; Robert Grützmann; Christian Pilarsky; Steven Gallinger; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2011-06-07       Impact factor: 5.911

6.  Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice.

Authors:  Shirley Oghamian; Nicole M Sodir; Muhammad U Bashir; Hui Shen; Andrea E Cullins; Cindy A Carroll; Pratima Kundu; Darryl Shibata; Peter W Laird
Journal:  Carcinogenesis       Date:  2011-03-01       Impact factor: 4.944

7.  The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.

Authors:  Brian C Lewis; David S Klimstra; Harold E Varmus
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

8.  Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.

Authors:  Jennifer Kl Colby; Russell D Klein; Mark J McArthur; Claudio J Conti; Kaoru Kiguchi; Toru Kawamoto; Penny K Riggs; Amy I Pavone; Janet Sawicki; Susan M Fischer
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

9.  Pancreatic acinar cell carcinoma: a multi-institutional study.

Authors:  Jesus M Matos; C Max Schmidt; Olivier Turrini; Narasimhan P Agaram; Marco Niedergethmann; Hans Detlev Saeger; Nipun Merchant; Cynthia S Johnson; Keith D Lillemoe; Robert Grützmann
Journal:  J Gastrointest Surg       Date:  2009-06-03       Impact factor: 3.452

Review 10.  Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer.

Authors:  Chi-Hin Wong; You-Jia Li; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.